<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W. Jenkins, Mei-Ju Su, Susanna Stinson et al.|Cancer Discovery|2017Cited by 591
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neckGlenn J. Hanna, Peter S. Hammerman, Hongye Liu et al.|Oral Oncology|2017Cited by 89
Cytotoxic T Cells in PD-L1–Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive FactorsMark M. Awad, Raphael Bueno, Robert E. Jones et al.|Cancer Immunology Research|2016Cited by 71
Supp. Movie 3 from <i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W. Jenkins, Mei-Ju Su, Amir Reza Aref et al.|Unknown|2023Cited by 0
Table S4 from <i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W. Jenkins, Mei-Ju Su, Amir Reza Aref et al.|Unknown|2023Cited by 0